123 related articles for article (PubMed ID: 3074839)
1. Neoplastic transformation of 3T3 mouse embryo cells with c-myc- and c-Ha-ras-1 oncogenes.
Armelin HA; Armelin MC; Kovary K
Braz J Med Biol Res; 1988; 21(6):1155-61. PubMed ID: 3074839
[TBL] [Abstract][Full Text] [Related]
2. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
Endlich B; Salavati R; Sullivan T; Ling CC
Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
[TBL] [Abstract][Full Text] [Related]
3. Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independent and cause tumors in newborn hamsters.
Takahashi M; Barrett JC; Tsutsui T
Int J Cancer; 2002 Jun; 99(5):629-34. PubMed ID: 12115494
[TBL] [Abstract][Full Text] [Related]
4. Transformation of rodent immortalized and embryo cells by oncogenes. I. Mouse (NIH 3T3) and rat (FR 3T3) immortalized fibroblasts.
Denner J; Ehm I; Jandrig B; Friese D
Arch Geschwulstforsch; 1987; 57(6):463-74. PubMed ID: 3435225
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
6. Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor.
Stern DF; Roberts AB; Roche NS; Sporn MB; Weinberg RA
Mol Cell Biol; 1986 Mar; 6(3):870-7. PubMed ID: 3022135
[TBL] [Abstract][Full Text] [Related]
7. [Interaction of growth factors and oncogenes in the tumorous transformation of cells].
Ivashchenko IuD; Osipova LA
Eksp Onkol; 1986; 8(2):9-17. PubMed ID: 3009133
[TBL] [Abstract][Full Text] [Related]
8. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
Thomassen DG; Gilmer TM; Annab LA; Barrett JC
Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.
Campisi J; Gray HE; Pardee AB; Dean M; Sonenshein GE
Cell; 1984 Feb; 36(2):241-7. PubMed ID: 6692471
[TBL] [Abstract][Full Text] [Related]
11. [The characteristics of the regulation of the cellular proliferation of embryonic rat fibroblasts transformed by E1A+c-Ha-ras oncogenes].
Blagosklonnyĭ MV; Darieva ZA; Pospelova TV
Vopr Onkol; 1991; 37(3):303-10. PubMed ID: 2031324
[TBL] [Abstract][Full Text] [Related]
12. Functional role for c-myc in mitogenic response to platelet-derived growth factor.
Armelin HA; Armelin MC; Kelly K; Stewart T; Leder P; Cochran BH; Stiles CD
Nature; 1984 Aug 23-29; 310(5979):655-60. PubMed ID: 6088986
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
14. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
[TBL] [Abstract][Full Text] [Related]
15. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
[TBL] [Abstract][Full Text] [Related]
17. Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens.
Yasutake C; Kuratomi Y; Ono M; Masumi S; Kuwano M
Cancer Res; 1987 Sep; 47(18):4894-9. PubMed ID: 2441855
[TBL] [Abstract][Full Text] [Related]
18. Preneoplastic potential of morphologically distinct transformed foci induced by 3-methylcholanthrene.
Keshava N; Keshava C; Whong WZ; Hubbs AF; Nath J; Ong T
Environ Mol Mutagen; 1998; 32(4):369-76. PubMed ID: 9882012
[TBL] [Abstract][Full Text] [Related]
19. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.
Ridley AJ; Paterson HF; Noble M; Land H
EMBO J; 1988 Jun; 7(6):1635-45. PubMed ID: 3049071
[TBL] [Abstract][Full Text] [Related]
20. Neoplastic transformation dose response of oncogene-transfected rat embryo cells by gamma rays or 6 MeV alpha particles.
Ling CC; Weiss H; Strauss A; Endlich B; Sheh Y; Wei JX; Orazem J
Radiat Res; 1994 Apr; 138(1):79-85. PubMed ID: 8146303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
